Tarsus Eyelid Patch header

Nictavi Partners & Eyelid Patch Market

The Tarsus Eyelid Patch addresses specific needs not met anywhere else in the market.

Vision & Eye Care
Market Statistics

Estimated Total Market Size:

Our patents secure our place in the growing vision care market, which was valued in 2023 at 125 Billion dollars, and will be 192 Billion by 2026.

2015

8.22% of the population are diagnosed with eye disorders. = 3,616,800 people.

2,000,000 people are diagnosed with Amblyopia Lazy eye yearly. Eye occlusion is the common treatment for this condition.

There are 46,000 cornea transplants annually in the United States at a cost of an estimated $840,000,000. If a portion of those, and other cornea surgeries can be avoided by preventing the cornea damage, it would reduce patient’s pain, suffering, and expense, while preserving their sight.

2016

48.04% of the population are diagnosed with cataracts. = 21,000,000 people.

5.41% of the population are diagnosed with cornea disorders. = 17,690,700 people.

2.36% of the population suffer eye injuries, burns, surgical complications. = 1,038,400 people.

5.54% of the population are diagnosed with diabetic eye diseases. = 2,437,600 people.

Eye Stats: https://www.aao.org/newsroom/eye-health-statistics

Supporters &
Strategic Partners

Nictavi works with and is supported by some of the top eye vision and eye care brands in the world.

5cad46d56cfca985ccb77292 Screen Shot 2019 04 09 at 6.28.14 PM

CTIP: Consortium for Technology and Innovation in Pediatrics

Pediatric MedTech Accelerator

247636 Stein Eye Color RGB large

Dr. Anthony Aldave

Early Supporter

Head of the Cornea Division of the Jules Stein Eye Institute.

UCLA Jules Stein Eye Institute

100 Stein Plz, Los Angeles, CA 90095

1-310-825-5000

scalehealth

ScaleHealth

Early Supporter

c3dde11c295c0c050cdd1686b51af838

Children’s Hospital of Los Angeles Vision Center

americas sbdc vector logo

Small Business Development Center

SBDC At Pasadena City College, East Foothill Boulevard, Pasadena, Los Angeles, CA

Don Loewel, Albert Napoli, and Julie Zwissler

hi tech logo

Hi-Tech Products

Contracted Manufacturer

Prototype development and manufacturing.

8530 Roland St. Buena Park, CA 90621

1-800-725-7793

Contacts: Mike Lohman, Fred Haag

USC Roski logo 1200x600 1

USC Roski Eye Institute

FDA Logo

Food and Drug Administration

A doctor in a mask
Operating table
Example of an eyeball

The Tarsus Eyelid Patch Serves a Need Across the Entire Vision Care Market

Ophthalmologists and Optometrists

Used as a therapeutic to achieve more patient compliant eyelid closure for the healing corneal epithelial defects, treating Lagophthalmos, keratopathy, and after some eye surgeries, as well as a treatment for other corneal health issues.

Enhancing applicable therapies that requires eyelid closure, improving patient compliance and outcomes.

Pediatricians

To address lazy eye and other eye health issues that may be addressed by eyelid closure.

In the ICU

To achieve eyelid closure for patients in medically induced comas, as to avoid cornea damage. Due to insufficient eyelid closure corneal defects occur in 20–42% of ICU patients, and 60% of those sedated for 48 hours.

Oculoplastic Surgeons
Over-the-counter (OTC)
Hospital Groups
Distributors
Pharmaceutical companies

To accompany their eye medicines. There have been studies that show that eyelid closure enhances the delivery and increasing effectiveness of some eye medicines.

The Military – Defense Health Agency (DHA) and the VA
Anesthesiologists

Anesthesiologists

Global Markets

In the News with Nictavi

smiling man

Meilleure solution pour la fermeture des paupières

smiling man

Mejor solución para el cierre de los párpados

smiling man

Better Solution for Eyelid Closure

Shopping Cart
Scroll to Top